Full text is available at the source.
Abstract
TMAO may be linked to neuroinflammation and cognitive dysfunction.
- TMAO is produced in the liver from trimethylamine, a compound derived from gut bacteria.
- Increasing evidence suggests a connection between TMAO and neurological disorders via the gut-brain axis.
- Potential mechanisms include neuroinflammation, oxidative stress, and activation of inflammatory pathways.
- TMAO and its precursors could serve as therapeutic targets for neurodegenerative disorders.
- There is a need for large, well-designed randomized clinical studies to clarify TMAO's therapeutic relevance.
Simplified